Daniel Thiel
Corporate Officer/Principal presso NanoSmart Pharmaceuticals, Inc.
Provenienza dei contatti di primo grado di Daniel Thiel
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
NanoSmart Pharmaceuticals, Inc.
 NanoSmart Pharmaceuticals, Inc. BiotechnologyHealth Technology NanoSmart Pharmaceuticals, Inc. is a privately-held corporation based in Laguna Hills, CA. The private company is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to enable targeted drug delivery of existing drug therapies to areas of necrosis present in virtually all solid cancer tumors. Henry J. Smith has been the CEO of the company since 2006.
4
| Private Company | Biotechnology | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Daniel Thiel tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Epinex Diagnostics, Inc.
 Epinex Diagnostics, Inc. Medical SpecialtiesHealth Technology Epinex Diagnostics, Inc. provides medical diagnostics tests and services. It develops multi-parameter diagnostic tests that use disposable strips and biosensors. The company provides services to the hospitals, emergency rooms, wholesale distributors and pharmacies. Epinex Diagnostics was founded in 2002 and is headquartered in Tustin, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| TRUSTFEED CORP. | Financial Conglomerates | President | |
Alpha Therapeutic Corp.
 Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Biotechnology | Corporate Officer/Principal | |
| University of Leeds | College/University | Doctorate Degree | |
| Oregon State University | College/University | Undergraduate Degree | |
| University of California, Irvine | College/University | Doctorate Degree | |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
| Diabetes Reference Services, Inc. | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 10 |
| Regno Unito | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
| Finance | 2 |
Posizioni
| Corporate Officer/Principal | 5 |
| President | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Paul F. Glidden | 7 |
| Henry J. Smith | 5 |
| James Smith | 1 |
| Kay Metis | 1 |
- Borsa valori
- Insiders
- Daniel Thiel
- Connessioni Società
